News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Finance
SteadyMed Raises $12.2 Million In Equity Financing 1/29/2015
Medical Research Council Announced A £4.8 Million Investment 1/29/2015
InVivo Therapeutics Corporation (NVIV) Announces $12 Million Registered Direct Offering 1/29/2015
XenoPort, Inc. (XNPT) Announces Pricing Of $100 Million 2.50% Convertible Senior Notes Due 2022 1/29/2015
Exco InTouch Set For Further Growth And Expansion Into Healthcare Markets Through Recent £3.2 Million Investment Round 1/29/2015
Vaccinogen Closes Second Tranche Of $80 Million Financing At $5.50 Per Unit 1/28/2015
BIONEXT Raises €1M In Seed Funding From The Cap Innov'Est Fund And Angel Investors 1/28/2015
Bill & Melinda Gates Foundation, UK Take Lead In $7.5 Billion Pledge For Children's Vaccines 1/28/2015
Vaccinogen Closes Second Tranche Of $80 Million Financing At $5.50 Per Unit 1/28/2015
Pfizer (PFE)'s $33 Billion Cash Pile Has Everyone Speculating 1/27/2015
ONCOLIX, INC. Announces Capital Raise Of $4.2 Million 1/27/2015
TxCell Receives EUR 1.7 Million From Bpifrance For Ovasave® Clinical Development In Refractory Crohn’s Disease 1/27/2015
THERAVECTYS Secures €1.9 Million From Bpifrance 1/26/2015
Forbion Capital Partners Leads CAD 13.5 Million (EUR 9.6 Million) Series B Financing Round For enGene, Inc. 1/26/2015
BIND Therapeutics (BIND) Amends Credit Facility From Hercules Technology III, L.P. To Accelerate Accurin Pipeline Growth 1/26/2015
Senator Wants Big Drugmakers That Break The Law To Fund NIH 1/23/2015
CytoSorbents, Inc. Receives $385,000 In Non-Dilutive Funding From The New Jersey Technology Business Tax Certificate Transfer Program 1/23/2015
With Ties to Eli Lilly (LLY), Innovent Biologics Scores $100 Million 1/22/2015
With $30 Million, REGENXBIO to Finance a Round of New Hires 1/22/2015
Cornerstone Pharmaceuticals, Inc. Receives Funding Through New Jersey's Technology Business Tax Certificate Transfer Program 1/22/2015
Aldeyra Therapeutics (ALDX) Completes $2 Million Private Placement 1/22/2015
Genetic Technologies Limited (GTG.AX) Secures A$24 Million Standby Equity Placement Facility 1/22/2015
goBalto, Inc. Raises $12 Million From Mitsui Global Investment And Dolby Family Ventures 1/21/2015
Alnylam Pharmaceuticals (ALNY) Banks $450 Million to Fund Ambitious Pipeline Goals 1/21/2015
Keryx Biopharmaceuticals (KERX) Announces $100 Million Proposed Public Offering Of Common Stock 1/21/2015
Endonovo Therapeutics Enters Into A $3 Million Equity Purchase Agreement With Kodiak Capital Group, LLC 1/21/2015
Navidea Biopharmaceuticals (NAVB)’s Macrophage Therapeutics Unit Announces Plan For $2.5 Million Financing 1/21/2015
D-Pharm Succeeds To Raise 12.8M NIS In Rights Offering 1/21/2015
The Children's Hospital of Philadelphia Announces $50 Million Gift To Fund Clinical And Research Transformation 1/21/2015
Deinove Successfully Completes The First Key Milestone Of Its Deinochem Program And Receives 1 Million Euros 1/21/2015
Minerva Neurosciences, Inc. (NERV) Announces $15 Million Debt Facility With Oxford Finance LLC And Silicon Valley Bank 1/20/2015
Agile Therapeutics, Inc. Announces $20 Million Private Placement And Provides Clinical Trial Update 1/20/2015
Aldeyra Therapeutics (ALDX) Announces $2 Million Private Placement 1/20/2015
EcoPesticides Closes Series A Round 1/20/2015
Rotary Releases US$34.8 Million To End Polio Worldwide 1/20/2015
Gecko Biomedical Receives 1.3 Million Euros From Bpifrance To Advance Its Bio-Inspired Surgical Adhesive Solutions 1/20/2015
Sensorion, The Specialist In Inner Ear Diseases, Completes A New Funding Round To Begin The Human Clinical Trial Phase 1/20/2015
Johnson & Johnson (JNJ) Lands $115 Million to Speed Up Development of Ebola Vaccine 1/19/2015
Burnet Institute Lands $4 Million From GuoMinXinHe Investment Fund 1/16/2015
VC Firm CTI BioPharma Collects $112 Million for New Biotech Fund 1/15/2015
Aldeyra Therapeutics (ALDX) Completes $7.79 Million Private Placement 1/15/2015
Clinipace Worldwide Closes On $50 Million M&A War Chest 1/15/2015
TruMed Systems Graduates EvoNexus Incubator With $5.5M In Series B Funding 1/14/2015
NeuroPhage Pharmaceuticals, Inc. Expands Series D Financing To $27 Million 1/14/2015
Baiyunshan Pharma Raises $1.6 Billion In Secondary Offering 1/14/2015
Aldeyra Therapeutics (ALDX) Announces $7.79 Million Private Placement 1/13/2015
Cortendo AB Raises Up To $27.5 Million In Additional Private Placement With Leading U.S. And EU Healthcare Investors 1/13/2015
EffRx Raises USD 2.3 Million In Internal Fundraising 1/12/2015
Capricor Therapeutics, Inc. Announces $10 Million Private Placement Of Common Stock 1/12/2015
Cure Duchenne Ventures LLC To Provide $1 Million To Capricor Therapeutics, Inc. To Advance Promising Research To Treat Heart Disease Associated With Duchenne Muscular Dystrophy 1/12/2015
Stealth Therapeutics, Inc. Expands Clinical Development For Mitochondrial Therapies 1/9/2015
Cerulean Pharma Inc. (CERU) Secures Debt Facility From Hercules Technology Growth Capital Of Up To $26 Million 1/9/2015
Seventure Invests EUR 1 M (USD 1.25 M) In First Investment Round For MaaT Pharma™ 1/9/2015
Backed by Some Very Big Names, Cambridge Startup Surface Oncology Reels in $35 Million 1/9/2015
Xeris Pharmaceuticals Completes $17.9M Series B Round And Appoints Phillip Johnson As Chief Financial Officer 1/8/2015
XRpro Sciences Announces Completion Of Equity Financing 1/8/2015
RetroSense Therapeutics Raises $6 Million In Series A Financing To Further Develop Lead Product RST-001 For Retinitis Pigmentosa 1/8/2015
Trevi Therapeutics Closes $15 Million Debt Facility Provided By Solar Capital And Square 1 Bank 1/8/2015
NovoCure Ltd. Announces $100 Million Term Loan Agreement With Pharmakon Advisors 1/8/2015
Hua Medicine Raises $25 Million In Series B Financing To Start Phase 2 Trials 1/8/2015
Vaxart, Inc. Completes Financing To Fund Expanding Development Portfolio 1/8/2015
Adaptive Biotechnologies Banks $94 Million, Buys Bay Area's Sequenta, Inc. 1/8/2015
Tiny Biotech Vtesse Nabs $25 Million and a Deal With the NIH 1/7/2015
Nestle Health Science Bets $65 Million On Biotech Startup 1/7/2015
Retooled Blend Therapeutics Locks in $21 Million 1/7/2015
BrainStorm Cell Therapeutics Inc. Announces Receipt Of Approximately $3.1 Million From Warrant Exercises 1/7/2015
Massachusetts Biotech Moderna Therapeutics, Inc. Raises Record $450 Million; Will Hire 100 New Staffers 1/7/2015
GenKyoTex S.A. Raises CHF 20 Million ($21 Million) 1/7/2015
Fosun Pharma To Double R&D Budget: $800 Million In 2016-2020 1/6/2015
EnGeneIC Pty Ltd Completes $10 Million Series B Financing Led By U.S. Institutional Investor 1/6/2015
CutisPharma Inc. Closes Equity Financing With Ampersand Ventures 1/6/2015
Pfizer (PFE) Leads South San Francisco Biotech CytomX Therapeutics, Inc. to $20 Million Funding Round 1/6/2015
Bay Area Pharma Global Blood Therapeutics Banks $48 Million 1/6/2015
Berkeley's Aduro Biotech Banks $51.4 Million 1/5/2015
Celator Pharmaceuticals, Inc. Receives $1,937,000 from New Jersey's Technology Business Tax Certificate Transfer Program 1/5/2015
Symic Biomedical Secures $15 Million In Series A Financing 1/5/2015
AntriaBio Announces $7 Million Private Placement 1/5/2015
Bone Therapeutics Release: €1 Million Funding Secured From The Walloon Region To Investigate These Innovative Products For The Treatment Of Large Bone Defects 1/5/2015
CutisPharma Inc. Nabs $20 Million Funding 1/2/2015
Despite Roche (RHHBY) Dropping $595 Million Deal, Chiasma Inc. Bags $33.8 Million 1/2/2015
3-V Biosciences Announces Closing Of $28.5M Financing Round 12/31/2014
Bay Area BioPharma 3-V Biosciences Reels in $28.5 Million 12/30/2014
PlasmaTech Biopharmaceuticals, Inc. Announces Closing Of Public Offering 12/29/2014
Dynavax Technologies Corporation (DVAX) Secures $40 Million Credit Facility With Hercules Technology Growth Capital 12/29/2014
Philanthropists John And Leslie Malone Propel Regenerative Medicine With Record $42.5 Million Gift To {1} 12/29/2014
Berkeley's Dynavax Technologies Corporation (DVAX) Secures $40 Million Credit Facility 12/29/2014
Palatin Technologies (PTN) Completes $20 Million Equity And $10 Million Debt Financings 12/24/2014
Interleukin Genetics Inc. (ILGN) Raises $10 Million In Financings 12/24/2014
Conkwest Nabs $50 Million and Snags Biotech Billionaire as Co-Chairman of the Board 12/24/2014
Vermillion Announces Equity Financing Of Up To $18.9 Million; Suspends ATM Program 12/23/2014
Advaxis, Inc. Completes $17 Million Financing 12/22/2014
61st Annual Free Care Fund Benefit Show On KDKA Showcases More Than $2.1 Million Raised For Children's Hospital Of Pittsburgh Foundation 12/22/2014
Google Inc. Arm Shifts Focus To Life Sciences; Has 2015 $425 Million Budget 12/19/2014
Nymox Pharmaceutical (NYMX) Announces $1.07 Million Financing 12/19/2014
Amarantus BioSciences, Inc. Announces Second Closing Of Series E Preferred Financing 12/19/2014
Novogen Limited (NVGN) Raises An Additional A$1.75m In Private Placement To US Institutions For Aggregate Private Placement Of A$5.85m 12/19/2014
The Fonds de solidarité FTQ Invests $4 Million In Zymeworks In Support Of Québec’s Health Sciences Sector 12/19/2014
MA Startup Padlock Therapeutics Reels In $23 Million 12/18/2014
Scioderm Locks In $20 Million Series B 12/18/2014
UK Unveils Ambitious £6 Billion Plan For Science And Innovation 12/17/2014
Novogen Limited (NVGN) Raises A$4.1 Million In Private Placement To US Institutions 12/17/2014
Acesion Pharma Raises 15.2 Million DKK In New Equity From Novo A/S And 12/17/2014
Celgene (CELG)-Backed Startup Flexus Biosciences Secures $38 Million 12/17/2014
Cambridge Major Laboratories, Inc.'s $20 Million Expansion To Create 75 New Jobs 12/17/2014
$12M Investment In Orphan Drug Company Nutrinia, Brings Hope To Pre-Term And Short Bowel Syndrome Infants 12/16/2014
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014
Queen Mary Spinout Steathyx Therapeutics Ltd. Secures £2m Series A Funding 12/16/2014
Crescendo Biologics' Receives Further Investment From Astellas Venture Management To Develop Novel Humabody Therapeutics Targeting Immune Checkpoint Inhibitors 12/16/2014
Beactica Closes Financing Round Successfully To Progress Epigenetic Drug Discovery Programmes 12/15/2014
ADMA Biologics, Inc. Receives $5M Tranche From Hercules Technology Growth Capital 12/15/2014
VECT-HORUS: New Equity Issue Of 1.5 MEU To Finance The Preclinical Development Of Its First Vectorized Product 12/15/2014
BerGenBio AS Completes NOK90 Million Fundraising 12/15/2014
Suzhou's Adagene Raises $8 Million For Antibody Discovery 12/15/2014
NetScientific Invests In Next Generation, Immunotherapeutics Company, PDS Biotechnology Corporation 12/15/2014
€6 Million In New Capital And New CEO For Cristal Therapeutics 12/15/2014
Nestle SA Makes Push Into Skin Care With 10 R&D Centers Worldwide; Has Budget Of $350 Million 12/11/2014
Bill & Melinda Gates Foundation-Backed Group Commits $300 Million To Ebola 12/11/2014
Carbios Release: Thanaplast™ Successfully Completes The Second Stage Of Its Development 12/11/2014
Albany Molecular Research, Inc. (AMRI) (AMRI) Spells Out Plan For Spending $50 Million 12/11/2014
Bacterioscan Inc. Concludes Series A Financing 12/11/2014
Soligenix (SNGX) Receives $617,000 In Non-Dilutive Financing From New Jersey's Technology Business Tax Certificate Transfer Program 12/11/2014
Agios Pharmaceuticals (AGIO) Announces Pricing Of $220 Million Public Offering Of Common Stock 12/11/2014
Aspen Park Pharmaceuticals, Inc. Men’s Health Company, Raises Series A Funding 12/11/2014
SF VC Firm Versant Ventures Wraps Up $305 Million Healthcare Fund 12/11/2014
Banting & Best Diabetes Centre Receives $1 Million Investment From AstraZeneca Canada Inc. (AZN) 12/10/2014
Industrifonden Joins Glionova SEK 42 Million ($5.7 Million) Financing Co-Led By Healthcap And Novo To Take Novel Therapy For Glioblastoma Into Clinic 12/9/2014
PCORI Board Approves Providing Up To $50 Million For CER On Hepatitis C 12/9/2014
NOVACYT Announces A €3.1M Capital Raise And Prepares For New Market Launches 12/9/2014
Adagene Inc. Closes $8 Million Series A Financing With Fidelity Biosciences, Fidelity Asia Growth, And Wuxi Venture Fund 12/8/2014
Integra Holdings Closes $3 Million Investment From Guangxi Wuzhou Pharmaceutical Group 12/8/2014
Paul G. Allen To Give $100 Million To Create Cell Science Institute 12/8/2014
Mercury Bets On "Midcontinent" With New $105M Seed Fund 12/5/2014
Metabiota Awarded Funding By European Commission (EC) To Help In Fight Against Ebola 12/5/2014
$25 Million Gift from Gale and Ira Drukier Creates the Drukier Institute for Children's Health at Weill Cornell Medical College 12/5/2014
Elekta Donates USD 35,000 To Prostate Cancer Research 12/5/2014
Allena Pharmaceuticals, Inc. Rakes In $25M Series B Financing 12/4/2014
Evgen Pharma Will Float £20M IPO To Fund Cancer Drug Trials 12/4/2014
AposTherapy Completes New Financing; Announces Global Expansion Initiatives 12/4/2014
Oramed Pharmaceuticals Inc. (ORMP) Raises $5 Million From Guangxi Wuzhou Zhongheng 12/4/2014
Protagonist Therapeutics Closes 2nd Tranche Of $18 Million Series B For Advancing Development Candidate To Clinical Trials In 2015 12/4/2014
San Francisco's Audentes Therapeutics Rakes In $42.5 Million Series B 12/3/2014
Biopharma Startup Naurex Inc. Scores $80 Million Series C Financing 12/3/2014
Trevena, Inc. (TRVN) Planning $40M Stock Offering 12/3/2014
Perrigo Company (PRGO) Announces The Closing Of Its Registered Public Offering Of Senior Notes 12/3/2014
ChromaDex, Inc. Receives $750,000 Cash From Previous Sale Of Its Bluscience Line 12/3/2014
AYOXXA BIOSYSTEMS Extends Series B 12/3/2014
Oramed Pharmaceuticals Inc. (ORMP) Closes $5 Million Investment From Guangxi Wuzhou Pharmaceutical Company 12/3/2014
Suven Life Sciences Ltd Raises INR 200 Cr Through A Qualified Institutions Placement (QIP) 12/3/2014
Seres Health Closes $48 Million Series C Financing 12/2/2014
PMV Pharmaceuticals Announces $30 Million Raised In Series A Financing 12/2/2014
reViral Receives Over US$1Mn In Funding 12/2/2014
Apellis Pharmaceuticals Raises $33M To Fund Its Complement Immunotherapy Programs 12/2/2014
Investment Firm Pumps $10 Million Into CANbridge Life Sciences 12/2/2014
Ally Bridge, A Hong Kong VC, Invests In German Biotech 12/1/2014
Sinopharm Raises $716 Million In Secondary Offering 12/1/2014
Abeona Therapeutics Raises Foundation-Led $3.6M To Develop Therapies For Children Suffering From Rare Sanfilippo Diseases 12/1/2014
Ascendis Pharma A/S Completes $60 Million Oversubscribed Series D Financing 12/1/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Announces Completion Of $280 Million In Financing Transactions 12/1/2014
Merrion Pharmaceuticals, Inc. Bids To Attract €52m Investment For Products 12/1/2014
Kite Pharma, Inc. (KITE) Files Registration Statement For Proposed Follow-On Offering 12/1/2014
Neothetics Announces Closing Of Upsized Initial Public Offering 12/1/2014
Axcelon Biopolymers Corp. Announces Closing Of Private Placement Financing In Its Woundcare Subsidiary 12/1/2014
Eleven Biotherapeutics (EBIO) Scores Additional $20 Million Financing 11/26/2014
CARsgen Closes Series A To Take Cancer Immunotherapy To Clinic 11/26/2014
Medgenics, Inc. Prices Public Offering of Common Stock 11/26/2014
CARsgen Completes Series A Financing 11/26/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Cell Medica Rakes In $78 Million Series B To Advance Cancer Program 11/25/2014
VC Polaris Partners Raises $450M For New Health Fund 11/25/2014
PROMETHERA Biosciences S.A./N.V. Raises $31.4 Million Series C 11/25/2014
Sinopharm Group To Rake In $716 Million From Share Placement 11/24/2014
Neovacs SA Granted 1 Million Euro In Research Tax Credit 11/24/2014
Genocea Biosciences Secures Debt Facility From Hercules Technology Growth Capital Of Up To $27 Million 11/21/2014
NephroGenex (NRX) Announces Closing Of $12 Million Term Loan Facility 11/21/2014
Manhattan Scientifics, Inc. Completes $2.0 Million Equity Raise 11/21/2014
Neovacs SA Secures A New Equity Line Financing With Kepler Cheuvreux 11/21/2014
Advaxis, Inc. To Receive $1.7M Through New Jersey Technology Business Tax (NOL) Program 11/20/2014
Northwest Biotherapeutics (NWBO) Reports $35M In Financing 11/20/2014
BioNano Genomics Raises $53 Million Series C 11/20/2014
Aequus Pharmaceuticals Closes $4.2 Million Private Placement Financing 11/20/2014
Cempra To Receive Biomedical Advanced Research and Development Authority (BARDA) Funding For 1b And Start-Up Of Phase 2/3 Solithromycin Pediatric Studies 11/19/2014
BeneVir Biopharm, Inc. Announces Investment From HC2’s Subsidiary Pansend, LLC 11/19/2014
Charity Alliance To Sink £30m Into Brain Disease Research 11/19/2014
N30 Pharma Secures $30 Million In Oversubscribed Crossover Financing 11/19/2014
Newly Formed Intellia Therapeutics Announces $15 Million In Funding 11/18/2014
Paulson Opens New Stake In AbbVie (ABBV), Nearly Triples Shire Shares 11/18/2014
Renova Therapeutics Welcomes New Board Member, Raises $7.52 Million In Series C Financing Round 11/18/2014
A New Venture Fund: Baird's Got $185 Million To Play With 11/18/2014
The Duchenne Alliance Commits $500,000 To Jerry Mendell M.D. And Milo Biotechnology To Fund First Duchenne Follistatin Gene Therapy Trial 11/17/2014
Riffyn Secures $1.8 Million Seed Financing to Advance Reproducible Research - O’Reilly AlphaTech Ventures Leads the Financing Round 11/17/2014
BeiGene Co.,Ltd Bags $75 Million 11/14/2014
The Government Of Canada Provides Support To Ciclofilin Pharmaceuticals For The Pre-Clinical Development Of Its Lead Drug 11/13/2014
Glionova Therapeutics Secures Sek 42 Million ($5.7 Million) Co-Lead By Healthcap And Novo To Take Novel Therapy For Glioblastoma Into Clinic 11/12/2014
OXIS International, Inc. (OXIS) Announces Oxis Biotech Inc., Completion Of $2.675 Million Financing, Appointment Of Chief Financial Officer And Board Member 11/12/2014
MA's Blueprint Medicines Scrounges Up $50 Million 11/12/2014
Navidea Biopharmaceuticals (NAVB) Receives $1.1Million PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Reaffirms Commitment To Line Of Credit 11/11/2014
AntriaBio Extinguishes $44 Million Contingent Liability 11/10/2014
Amarantus BioSciences, Inc. Reports Third Quarter 2014 Financial Results And Enters Into Strategic Preferred Financing 11/10/2014
Invion Limited Announces $17.4 Million Investment 11/10/2014
Histide Raises CHF 4.5 M (USD 4.6 M) Series A Investment Round to Advance Its Pioneering Recoding Therapeutics™ Technology 11/10/2014



//-->